Patent · US Active

Methods and devices for desmopressin drug delivery

US9375530B2 · kind B2 · utility

6Cited by
102References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 15, 2013
Grant dateJun 28, 2016
Priority date
Expiry dateFeb 28, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P13/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed are devices for urine voiding postponement, and methods for treating conditions such as central diabetes insipidus, enuresis, nocturia, urinary frequency or incontinence. The devices deliver a desmopressin flux through the skin of a patient in a low dose amount just necessary to achieve a desired anti-diuretic effect without undesirable side effects such as hyponatremia. The devices are designed to permit a state of normal urinary production to return quickly after the desmopressin flux is terminated.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.